Skip to content
Submit incident
AII-1002-00497
ReportedReported by fewer than three independent publishers, with no official finding.

Neuralink Brain Implants Raise Privacy and Ethical Concerns

Neuralink's N1 brain implant, developed by Elon Musk's company, has been implanted in seven people with spinal injuries or ALS, allowing them to control computers with their thoughts. The technology raises ethical concerns about access to personal neural data including thoughts, memories, and emotions.

24 June 2025 Β· Neuralink Β· Privacy and surveillance
24 June 2025
AII-1002-004972 sources ↓
Quick facts
Category
Privacy and surveillance
Country
United States
Source
Yahoo! Finance
Date
24 June 2025
Drafted by
Raidu Incident Detection

What happened

Neuralink, co-founded by Elon Musk, developed the N1 Implant, a coin-sized brain chip surgically embedded beneath the skull to create a brain-computer interface. The implant receives information from neural threads that fan into different brain sections and contains sensors capable of recording and emitting electrical currents.

In May 2023, the FDA approved Neuralink to begin human clinical trials. By February 2025, three people had received the implant; that number increased to five by June 2025 and to seven by late June. Six of the seven participants are enrolled in the PRIME study conducted by Barrow Neurological Institute in Phoenix, Arizona.

Reported impact

The implant allows patients with cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS) to control a computer cursor, type words, browse the web, and play video games using only their thoughts, without moving limbs or fingers. The technology is intended to help people with severe speech impairments and other neurological conditions improve quality of life.

Index analysis

The implant raises ethical and social concerns regarding access to deeply personal data. Collection and storage of thoughts, memories, and emotions through the brain-computer interface creates privacy risks. Neuralink's neural threads are surgically embedded in the brain, requiring neurosurgical robots to place them.

Governance controls

The FDA granted Neuralink Breakthrough Device Designation in May 2025, which aims to speed up review and development of technologies addressing serious conditions. The PRIME study aims to prove that the N1 implant, R1 surgical robot, and N1 User App are safe and effective.

Classification

Category
Privacy and surveillance
Industry
Healthcare, drugs and biotechnology
Country
United States
Harm status
Potential harm
Intent
Unknown
Timing
Unknown
Harm types
Human or fundamental rights
AI systems
N1 Implant (Link)
Regulations
FCRA (cited)

Sources and evidence

This record was researched and written by the Index, based on the following original reporting.

Yahoo! Finance
Elon Musk's Neuralink: Innovation amid an ethical minefield
24 June 2025
PC Mag Middle East
7 People Now Have Elon Musk's Neuralink Brain Implant
27 June 2025